Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Heart Failure | 20 | 2021 | 6638 | 1.04 | Why? |
| Tobacco Mosaic Virus | 1 | 2020 | 14 | 0.88 | Why? |
| Patient Dropouts | 1 | 2018 | 96 | 0.74 | Why? |
| Desensitization, Immunologic | 3 | 2019 | 574 | 0.66 | Why? |
| Omalizumab | 1 | 2018 | 158 | 0.63 | Why? |
| Laboratories, Hospital | 1 | 2020 | 489 | 0.59 | Why? |
| Asthma | 4 | 2020 | 4383 | 0.53 | Why? |
| Anti-Asthmatic Agents | 1 | 2018 | 427 | 0.52 | Why? |
| Ventricular Dysfunction, Right | 2 | 2018 | 639 | 0.52 | Why? |
| Allergens | 2 | 2018 | 728 | 0.50 | Why? |
| Hypersensitivity | 2 | 2018 | 1137 | 0.44 | Why? |
| Stroke Volume | 5 | 2021 | 2153 | 0.37 | Why? |
| Coronary Angiography | 1 | 2017 | 2275 | 0.34 | Why? |
| Preoperative Care | 1 | 2017 | 1515 | 0.33 | Why? |
| Ventricular Remodeling | 3 | 2018 | 349 | 0.32 | Why? |
| Heart Ventricles | 3 | 2018 | 1139 | 0.28 | Why? |
| Ventricular Function, Left | 3 | 2018 | 1555 | 0.28 | Why? |
| Ventricular Function, Right | 2 | 2018 | 388 | 0.28 | Why? |
| Heart Diseases | 2 | 2020 | 3503 | 0.26 | Why? |
| Mitral Valve Insufficiency | 2 | 2018 | 302 | 0.26 | Why? |
| Italy | 14 | 2021 | 38444 | 0.24 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.24 | Why? |
| Hemodynamics | 4 | 2018 | 1562 | 0.23 | Why? |
| Surgical Procedures, Operative | 1 | 2017 | 2662 | 0.22 | Why? |
| Ventricular Dysfunction, Left | 2 | 2020 | 993 | 0.21 | Why? |
| Heart Rupture, Post-Infarction | 1 | 2020 | 74 | 0.21 | Why? |
| Heart Aneurysm | 1 | 2020 | 46 | 0.21 | Why? |
| Hospitalization | 8 | 2021 | 54280 | 0.19 | Why? |
| Maltose | 1 | 2018 | 50 | 0.19 | Why? |
| Endomyocardial Fibrosis | 1 | 2018 | 27 | 0.19 | Why? |
| Heart Failure, Systolic | 1 | 2018 | 39 | 0.18 | Why? |
| Benzazepines | 1 | 2018 | 49 | 0.18 | Why? |
| Troponin T | 2 | 2020 | 771 | 0.18 | Why? |
| Echocardiography, Stress | 1 | 2018 | 65 | 0.18 | Why? |
| Proteasome Inhibitors | 1 | 2018 | 127 | 0.17 | Why? |
| Echocardiography, Doppler, Color | 1 | 2018 | 114 | 0.17 | Why? |
| Ferric Compounds | 1 | 2018 | 136 | 0.17 | Why? |
| Adrenergic beta-Antagonists | 2 | 2018 | 465 | 0.17 | Why? |
| Propanolamines | 1 | 2017 | 47 | 0.17 | Why? |
| Comorbidity | 10 | 2021 | 34796 | 0.17 | Why? |
| Death | 2 | 2018 | 334 | 0.17 | Why? |
| Exercise Test | 3 | 2019 | 911 | 0.17 | Why? |
| Familial Primary Pulmonary Hypertension | 1 | 2017 | 68 | 0.17 | Why? |
| Myocardial Infarction | 3 | 2018 | 3361 | 0.17 | Why? |
| Pulmonary Ventilation | 1 | 2019 | 152 | 0.17 | Why? |
| Atrial Fibrillation | 3 | 2021 | 2320 | 0.17 | Why? |
| Aminobutyrates | 1 | 2018 | 142 | 0.17 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 9335 | 0.16 | Why? |
| Oxygen Consumption | 2 | 2019 | 711 | 0.16 | Why? |
| Catheterization, Swan-Ganz | 1 | 2015 | 30 | 0.16 | Why? |
| Pericardial Effusion | 1 | 2020 | 312 | 0.16 | Why? |
| Anemia, Iron-Deficiency | 1 | 2018 | 210 | 0.16 | Why? |
| Carbazoles | 1 | 2017 | 120 | 0.15 | Why? |
| Patient Outcome Assessment | 1 | 2020 | 707 | 0.15 | Why? |
| Respiratory Function Tests | 2 | 2020 | 1755 | 0.15 | Why? |
| Tetrazoles | 1 | 2018 | 262 | 0.15 | Why? |
| Endpoint Determination | 1 | 2017 | 344 | 0.15 | Why? |
| Eosinophilia | 1 | 2018 | 292 | 0.15 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.15 | Why? |
| Aorta | 1 | 2018 | 355 | 0.14 | Why? |
| Smokers | 1 | 2020 | 550 | 0.14 | Why? |
| Cardiotonic Agents | 1 | 2018 | 418 | 0.14 | Why? |
| Troponin | 1 | 2021 | 1058 | 0.14 | Why? |
| Pericarditis | 1 | 2020 | 417 | 0.14 | Why? |
| Oligopeptides | 1 | 2018 | 576 | 0.14 | Why? |
| Eosinophils | 1 | 2021 | 848 | 0.14 | Why? |
| Hospital Mortality | 7 | 2021 | 22087 | 0.13 | Why? |
| Acute Disease | 4 | 2020 | 6029 | 0.13 | Why? |
| Pulmonary Medicine | 1 | 2020 | 706 | 0.13 | Why? |
| Mitral Valve | 1 | 2017 | 342 | 0.13 | Why? |
| Humans | 45 | 2021 | 930598 | 0.13 | Why? |
| Angiotensin II Type 1 Receptor Blockers | 1 | 2018 | 520 | 0.12 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2018 | 552 | 0.12 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.12 | Why? |
| Community Health Services | 1 | 2021 | 1000 | 0.11 | Why? |
| Echocardiography | 4 | 2018 | 3661 | 0.11 | Why? |
| Pulmonary Embolism | 2 | 2021 | 4775 | 0.11 | Why? |
| Rhinitis, Allergic | 1 | 2019 | 704 | 0.11 | Why? |
| Heart Transplantation | 2 | 2018 | 1293 | 0.11 | Why? |
| Follow-Up Studies | 9 | 2020 | 17020 | 0.11 | Why? |
| Leukocyte Count | 1 | 2021 | 3178 | 0.11 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.11 | Why? |
| Risk Factors | 10 | 2021 | 71621 | 0.10 | Why? |
| Diagnostic Imaging | 1 | 2018 | 1044 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Prognosis | 8 | 2021 | 32490 | 0.10 | Why? |
| Diagnostic Tests, Routine | 2 | 2020 | 2643 | 0.10 | Why? |
| Patient Readmission | 1 | 2018 | 1543 | 0.09 | Why? |
| Multiple Myeloma | 1 | 2018 | 1064 | 0.09 | Why? |
| Hypertension, Pulmonary | 1 | 2018 | 970 | 0.09 | Why? |
| Risk Assessment | 5 | 2021 | 25439 | 0.09 | Why? |
| Diastole | 2 | 2018 | 168 | 0.09 | Why? |
| Middle Aged | 21 | 2021 | 270681 | 0.09 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.09 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.09 | Why? |
| Disease Progression | 4 | 2021 | 13580 | 0.09 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.08 | Why? |
| Disease Susceptibility | 1 | 2020 | 4002 | 0.08 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.08 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.08 | Why? |
| Morbidity | 3 | 2018 | 1426 | 0.08 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.08 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.08 | Why? |
| Perioperative Care | 1 | 2017 | 1329 | 0.08 | Why? |
| Male | 22 | 2021 | 367725 | 0.08 | Why? |
| Pneumonia, Viral | 8 | 2021 | 243684 | 0.08 | Why? |
| Female | 22 | 2021 | 380317 | 0.08 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.08 | Why? |
| Aged | 14 | 2021 | 215776 | 0.07 | Why? |
| Biological Products | 1 | 2020 | 2331 | 0.07 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.07 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.07 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.07 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2020 | 3051 | 0.07 | Why? |
| Forecasting | 1 | 2019 | 4492 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Percutaneous Coronary Intervention | 1 | 2020 | 3646 | 0.07 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.06 | Why? |
| Cardiac Surgical Procedures | 1 | 2017 | 1931 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Protease Inhibitors | 1 | 2018 | 3630 | 0.06 | Why? |
| Quality of Life | 2 | 2020 | 9820 | 0.06 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.06 | Why? |
| Treatment Outcome | 8 | 2018 | 51732 | 0.05 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.05 | Why? |
| Partial Pressure | 1 | 2020 | 279 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Dobutamine | 1 | 2018 | 36 | 0.05 | Why? |
| Severity of Illness Index | 4 | 2020 | 48226 | 0.05 | Why? |
| Hyperemia | 1 | 2018 | 62 | 0.05 | Why? |
| Registries | 1 | 2018 | 12327 | 0.05 | Why? |
| Cross-Sectional Studies | 3 | 2020 | 53120 | 0.05 | Why? |
| Age Factors | 4 | 2021 | 21039 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 2 | 2018 | 3776 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2021 | 6543 | 0.04 | Why? |
| Systole | 1 | 2018 | 252 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Neprilysin | 1 | 2018 | 112 | 0.04 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.04 | Why? |
| Valsartan | 1 | 2018 | 206 | 0.04 | Why? |
| Biphenyl Compounds | 1 | 2018 | 249 | 0.04 | Why? |
| Tricuspid Valve Insufficiency | 1 | 2018 | 94 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2020 | 893 | 0.04 | Why? |
| Endothelium, Vascular | 2 | 2018 | 1751 | 0.04 | Why? |
| Echocardiography, Doppler | 1 | 2018 | 269 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.04 | Why? |
| Vasodilation | 1 | 2018 | 258 | 0.04 | Why? |
| Prosthesis Design | 1 | 2018 | 594 | 0.04 | Why? |
| Cardiac Imaging Techniques | 1 | 2018 | 357 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Administration, Intravenous | 1 | 2018 | 1115 | 0.03 | Why? |
| Vascular Stiffness | 1 | 2018 | 264 | 0.03 | Why? |
| Chronic Disease | 2 | 2020 | 5139 | 0.03 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.03 | Why? |
| Time Factors | 4 | 2018 | 31397 | 0.03 | Why? |
| Multimodal Imaging | 1 | 2018 | 534 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Survival Rate | 2 | 2018 | 9206 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.03 | Why? |
| Adult | 6 | 2020 | 244371 | 0.03 | Why? |
| Pulmonary Edema | 1 | 2017 | 430 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.03 | Why? |
| Global Health | 3 | 2020 | 13911 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2018 | 1289 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Young Adult | 2 | 2019 | 93724 | 0.03 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.03 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.03 | Why? |
| Shock, Cardiogenic | 1 | 2017 | 700 | 0.03 | Why? |
| Shock, Septic | 1 | 2020 | 1313 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2017 | 1887 | 0.02 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Peptide Fragments | 1 | 2020 | 2075 | 0.02 | Why? |
| Heart-Assist Devices | 1 | 2017 | 812 | 0.02 | Why? |
| Heart | 1 | 2018 | 1791 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Clinical Trials as Topic | 2 | 2018 | 7330 | 0.02 | Why? |
| Hemorrhage | 1 | 2020 | 3013 | 0.02 | Why? |
| Recovery of Function | 1 | 2018 | 2461 | 0.02 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.02 | Why? |
| Heart Rate | 1 | 2017 | 1527 | 0.02 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.02 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.02 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.02 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.02 | Why? |
| Cross Reactions | 1 | 2018 | 4374 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.02 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.02 | Why? |
| Prospective Studies | 2 | 2017 | 43301 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Mortality | 1 | 2015 | 7132 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Adolescent | 1 | 2019 | 86841 | 0.01 | Why? |
Lombardi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(217)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(147)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_